Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share capital and reserves (Tables)

v3.24.1.1.u2
Share capital and reserves (Tables)
12 Months Ended
Dec. 31, 2023
Share capital and reserves  
Summary of changes in warrants

​

​

​

​

​

​

​

​

    

​

    

Weighted  

​

​

Number of 

​

Average

​

    

Warrants

    

Exercise price

Balance, December 31, 2021

​

569,655

​

$

33.10

Granted – October 7, 2022

 

555,555

​

​

10.98

Balance, December 31, 2023 and 2022

 

1,125,210

​

$

22.31

Schedule of information on warrants outstanding

The following table summarizes information on warrants outstanding at December 31, 2023:

​

​

​

​

​

​

​

​

    

​

    

​

    

Remaining 

​

​

Number 

​

​

​

Contractual 

Exercise Price

    

Outstanding

    

Expiry date

    

Life

CAD$42.26

​

198,333

​

February 9, 2026

​

2.11 years

$42.93

​

270,211

​

October 15, 2026

​

2.79 years

$10.53

 

101,111

​

October 15, 2026

 

2.79 years

$10.98

​

555,555

​

October 7, 2027

​

3.77 years

Total

 

1,125,210

​

​

 

3.15 years

Schedule of the changes in pre-funded warrants

​

​

​

​

​

​

​

​

    

​

    

​

Weighted

​

​

Number of 

​

​

Average 

​

    

Warrants

    

​

 Exercise price

Balance, December 31, 2021

​

-

​

​

—

Granted – October 7, 2022

 

400,000

 

$

0.0009

Exercised

 

(71,223)

 

$

0.0009

Balance, December 31, 2022

​

328,777

​

$

0.0009

Exercised

​

(328,777)

​

$

0.0009

Balance, December 31, 2023

 

-

 

​

—

Schedule of changes in finders' warrants

​

​

​

​

​

​

​

​

    

​

​

Weighted  

​

​

Number of 

​

Average

​

    

Warrants

    

Exercise price

Balance, December 31, 2021

​

22,521

​

$

39.61

Granted – October 7, 2022

​

27,777

​

​

10.98

Balance, December 31, 2023 and 2022

 

50,298

​

$

23.89

Schedule of information on finders' warrants outstanding

The following table summarizes information on finders’ and underwriters warrants outstanding at December 31, 2023:

​

​

​

​

​

​

​

​

    

​

    

​

    

Remaining

​

​

Number

​

​

​

Contractual

Exercise Price

​

Outstanding

​

Expiry date

​

Life

CAD$42.30

​

6,377

​

February 9, 2026

​

2.11 years

$42.93

​

16,144

​

October 15, 2026

​

2.79 years

$10.98

​

27,777

​

October 7, 2027

​

3.77 years

Total

​

50,298

​

​

​

3.25 years

Schedule of fair value of stock options granted was estimated on the date of grant using the Black-Scholes mode

​

​

​

​

​

​

​

​

    

2023

    

2022

 

Dividend yield

 

Nil

 

Nil

​

Annualized volatility

 

100

%  

100

%

Risk-free interest rate

 

3.25

%  

1.44%-3.32

%

Expected life

 

5 years

 

5 years

​

Schedule of the changes in stock options for the years

​

​

​

​

​

​

​

​

    

​

    

Weighted 

​

​

Number of 

​

Average

​

    

Options

    

 Exercise price (CAD)

Balance, December 31, 2021

​

67,332

​

$

27.89

Granted – January 12, 2022

​

14,162

​

​

22.86

Granted – June 6, 2022

​

43,866

​

​

14.40

Granted – November 25, 2022

 

7,776

​

​

12.42

Expired

 

(4,896)

​

​

28.67

Balance, December 31, 2022

 

128,240

​

$

21.75

Granted – December 31, 2023

 

8,000

​

​

2.90

Expired

 

(32,318)

​

​

33.65

Balance, December 31, 2023

 

103,922

​

$

16.60

Vested and exercisable, December 31, 2023

 

89,872

​

$

16.54

Schedule of information on stock options outstanding and contractual remaining life

The following table summarizes information on stock options outstanding at December 31, 2023:

​

​

​

​

​

​

​

​

​

​

    

Number 

    

Number 

​

​

    

Remaining 

Exercise Price (CAD)

    

Outstanding

    

Exercisable

    

Expiry Date

    

Contractual Life

$14.76

​

14,669

​

14,669

​

June 23, 2025

​

1.48 years

$25.38

​

1,419

​

1,419

​

August 27, 2025

​

1.66 years

$29.61

​

6,624

​

6,624

​

January 11, 2026

​

2.03 years

$16.92

 

2,366

 

2,366

​

May 12, 2026

 

2.36 years

$21.69

 

4,732

 

3,811

​

July 14, 2026

 

2.54 years

$22.86

 

8,085

 

8,085

​

December 21, 2026

 

2.98 years

$22.86

 

11,940

 

7,628

​

January 12, 2027

 

3.04 years

$14.40

 

40,533

 

35,265

​

June 6, 2027

 

3.43 years

$12.42

 

5,554

 

2,005

​

November 25, 2027

 

3.90 years

$2.90

 

8,000

 

8,000

​

December 31, 2028

 

5.00 years

​

 

103,922

 

89,872

​

​

​

​

Schedule of the derivative warrant liabilities

​

​

​

​

​

Balance at December 31, 2020

    

$

—

Warrants issued February 9, 2021

​

 

4,212,000

Warrants exercised

​

 

(335,950)

Fair value reclassified to reserves

​

 

(3,506,565)

Warrants issued October 15, 2021

​

 

5,998,000

Fair value adjustment

​

 

(2,636,391)

Foreign currency translation adjustment

​

​

(104,719)

Balance at December 31, 2021

​

$

3,626,375

Warrants issued October 7, 2022

​

​

3,714,757

Fair value adjustment

​

​

(3,396,137)

Foreign currency translation adjustment

​

​

(90,592)

Balance at December 31, 2022

​

$

3,854,403

Reclassified from reserves

​

 

318,000

Fair value adjustment

​

 

(3,641,403)

Balance at December 31, 2023

​

$

531,000

Schedule of significant on assumptions used in determining the fair value of the derivative warrant liabilities

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

December 31, 

    

​

December 31, 

​

​

December 31, 

 

​

    

​

2023

    

​

2022

​

​

2021

​

Share price

​

$

2.31

​

$

7.29

​

$

18.45

 

Risk-free interest rate

 

​

3.25%-3.91

%  

​

3.55

%  

​

1.23

%

Dividend yield

 

​

0

%  

​

0

%  

​

0

%

Expected volatility

 

​

100

%  

​

100

%  

​

100

%

Remaining term (in years)

 

​

2.1-3.8

 

​

3.8-4.8

​

​

4.8

​